Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDrreddyslaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Phani Sekhar positive on largecap pharma space

      Phani Sekhar, Fund Manager--PMS at Karvy Stock Broking has a positive view on largecap pharma space.

    • Buy HDFC, SKS Micro, Dr Reddy's, Lupin: Ashish Chaturmohta

      Ashish Chaturmohta of Fortune Group recommends buying HDFC, SKS Microfinance, Dr Reddy's Labs and Lupin.

    • Your stocks: What to buy/sell/hold in volatile market

      Watch the interview of Sameet Chavan of Angel Broking who shared his readings and outlook on specific stocks and sector & Kalpesh Ashar of Full Circle Financial Planners & Advisors answered few personal finance queries.

    • Enter Sun Pharma, Dr Reddy's on dips: Sameet Chavan

      According to Sameet Chavan of Angel Broking, one may buy Sun Pharmaceutical Industries and Dr Reddy's Laboratories on dips.

    • Go long in Dr Reddy's Labs, target Rs 3700: Chaturmohta

      Ashish Chaturmohta of Fortune Group recommends going long in Dr Reddy's Laboratories for a target of Rs 3700.

    • Buy Lupin, Dr Reddy's Labs, BPCL: Ashish Chaturmohta

      Ashish Chaturmohta of Fortune Eqity Broker recommends buying Lupin, Dr Reddy's Labs and BPCL.

    • Pick L&T, BHEL, ICICI Bank, Sun Pharma: Sharmila Joshi

      Sharmila Joshi of sharmilajoshi.com recommends picking L&T, BHEL, ICICI Bank, HDFC Bank, Sun Pharma and Dr Reddy's Labs.

    • Exit Natco Pharma, buy Sun Pharma, Glenmark: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends exiting Natco Pharma and advises buying Glenmark Pharma, Dr Reddy's Laboratories and Sun Pharma at lower levels.

    • Buy Dr Reddy's Laboratories: Pritesh Mehta

      Pritesh Mehta of IIFL advises buying Dr Reddy's Laboratories.

    • Prefer Infosys, TCS, Axis Bank, HDFC Bank: Gaurang Shah

      Gaurang Shah of Geojit BNP Paribas Financial Services is of the view that one may prefer Infosys, HCL Technologies and Tata Consultancy Services from IT space.

    • Wockhardt in downtrend, looks weak: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that Wockhardt is in a downtrend and looks weak.

    • Glenmark, Dr Reddy's top picks: R Sreesankar

      R Sreesankar, Head-Institutional Equities at Prabhudas Lilladher is of the view that Glenmark Pharma, Dr Reddy's Laboratories and Aurobindo Pharma are the top picks from the pharma space.

    • FMCG, pharma space continue to outperform: Phani Sekhar

      Phani Sekhar of Karvy Stock Broking feels that FMCG and pharma space continue to outperform.

    • Buy Dr Reddys Laboratories, says Manish Hathiramani

      Manish Hathiramani of Deen Dayal Investments advises buying Dr Reddys Laboratories.

    • Buy Dr Reddy's Labs, Adani Enterprises; sell Exide: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Dr Reddy's Labs and Adani Enterprises and advises selling Exide Industries.

    • Top buzzing midcap stocks to trade on May 12

      Here are a few top buzzing midcap stocks picked by CNBC-TV18's analysts in trade today - Videocon, Jubilant Industries, Dr Reddy's Laboratories, Phoenix Mills, Motherson Sumi, Gujarat Gas, Union Bank & Hero MotoCorp.

    • Sell Dr Reddy's Laboratories, HDFC; buy AB Nuvo: Sukhani

      Sudarshan Sukhani of s2analytics.com recommends selling Dr Reddy's Laboratories and HDFC and advises buying Aditya Birla Nuvo.

    • Sell Dr Reddy's Laboratories, advises Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends selling Dr Reddys Laboratories as the stock may head lower.

    • Buy Lupin, says Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Lupin.

    • Look at pharma space: Ajay Bagga

      According to Ajay Bagga, Market Expert, one may look at pharma space.

    • Expect Cipla, Sun Pharma to head lower: Mithil Pradhan

      Mithil Pradhan of Violet Arc Global Managers is of the view that Cipla and Sun Pharma may head lower.

    • Invest in pharma sector: Dipan Mehta

      Dipan Mehta, Member at BSE & NSE is overweight in pharma sector and feels that it is good to invest in the space.

    • Stay away from pharma space, see deep correction: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may avoid the pharma space as it may witness deeper correction.

    • Prefer pharma, telecom stocks: Ajay Srivastava

      Ajay Srivastava, CEO at Dimensions Consulting is of the view that one may prefer pharma and telecom stocks as they are going to give the best returns in the next three to five years.

    • Look at healthcare space: Sandeep Shenoy

      Sandeep Shenoy of Pioneer Investcorp is of the view that one may look at healthcare space.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347